Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
GSK

GlaxoSmithKline

$38.62

-3.25 (-7.76%)

, TSRO

Tesaro

$73.51

27.23 (58.84%)

16:20
12/03/18
12/03
16:20
12/03/18
16:20
OnTheFly
Fly Intel: Wall Street's top stories for Monday »

Stocks opened sharply…

GSK

GlaxoSmithKline

$38.62

-3.25 (-7.76%)

TSRO

Tesaro

$73.51

27.23 (58.84%)

NXST

Nexstar

$88.25

5.61 (6.79%)

TRCO

Tribune Media

$45.04

4.8 (11.93%)

CVS

CVS Health

$79.51

-0.71 (-0.89%)

AET

Aetna

$212.28

(0.00%)

GBT

Global Blood Therapeutics

$46.73

15.17 (48.07%)

MO

Altria Group

$55.73

0.93 (1.70%)

AGIO

Agios Pharmaceuticals

$56.78

-9.03 (-13.72%)

TTWO

Take-Two

$103.43

-6.15 (-5.61%)

CRON

Cronos Group

$10.17

1.02 (11.15%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Dec

  • 03

    Dec

  • 03

    Dec

  • 03

    Dec

  • 03

    Dec

  • 03

    Dec

GSK

GlaxoSmithKline

$38.59

-3.28 (-7.83%)

, TSRO

Tesaro

$73.48

27.2 (58.77%)

12:09
12/03/18
12/03
12:09
12/03/18
12:09
OnTheFly
Fly Intel: Wall Street's top stories at midday »

Stocks soared at the open…

GSK

GlaxoSmithKline

$38.59

-3.28 (-7.83%)

TSRO

Tesaro

$73.48

27.2 (58.77%)

TRCO

Tribune Media

$44.21

3.97 (9.87%)

NXST

Nexstar

$84.50

1.86 (2.25%)

GBT

Global Blood Therapeutics

$45.84

14.28 (45.25%)

NBEV

New Age Beverages

$5.18

0.56 (12.12%)

AGIO

Agios Pharmaceuticals

$58.97

-6.84 (-10.39%)

ARQL

ArQule

$3.33

-0.37 (-10.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Dec

  • 03

    Dec

  • 03

    Dec

  • 03

    Dec

  • 03

    Dec

  • 03

    Dec

  • 03

    Dec

  • 04

    Dec

AGIO

Agios Pharmaceuticals

$62.26

-3.55 (-5.39%)

10:19
12/03/18
12/03
10:19
12/03/18
10:19
Hot Stocks
Agios reports updated data from Phase 1 ivosidenib, enasidenib study »

Agios Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AGIO

Agios Pharmaceuticals

07:50
11/30/18
11/30
07:50
11/30/18
07:50
Recommendations
Agios Pharmaceuticals analyst commentary at Canaccord »

Agios differentiation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Dec

AGIO

Agios Pharmaceuticals

$67.30

-0.95 (-1.39%)

, CELG

Celgene

$70.67

-0.33 (-0.46%)

13:19
11/29/18
11/29
13:19
11/29/18
13:19
Hot Stocks
FDA warns symptoms of serious condition not being recognized in Idhifa users »

The U.S. Food and Drug…

AGIO

Agios Pharmaceuticals

$67.30

-0.95 (-1.39%)

CELG

Celgene

$70.67

-0.33 (-0.46%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Dec

  • 02

    Dec

  • 03

    Dec

AGIO

Agios Pharmaceuticals

$67.26

3.54 (5.56%)

07:16
11/16/18
11/16
07:16
11/16/18
07:16
Hot Stocks
Agios Pharmaceuticals presents data from AG-881 study at SNO »

Agios Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Dec

Over a month ago
AGIO

Agios Pharmaceuticals

$62.14

-0.9 (-1.43%)

11:07
11/01/18
11/01
11:07
11/01/18
11:07
Recommendations
Agios Pharmaceuticals analyst commentary at Piper Jaffray »

Piper says Agios pull…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Nov

AGIO

Agios Pharmaceuticals

$62.26

-0.78 (-1.24%)

, CELG

Celgene

$75.15

3.54 (4.94%)

11:00
11/01/18
11/01
11:00
11/01/18
11:00
Hot Stocks
Agios sees submitting sNDA for TIBSOVO by end of January 2019 »

Agios Pharmaceuticals…

AGIO

Agios Pharmaceuticals

$62.26

-0.78 (-1.24%)

CELG

Celgene

$75.15

3.54 (4.94%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Nov

  • 12

    Nov

AGIO

Agios Pharmaceuticals

$63.04

3.3 (5.52%)

07:25
11/01/18
11/01
07:25
11/01/18
07:25
Earnings
Agios Pharmaceuticals reports Q3 EPS ($1.63), consensus ($1.62) »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Nov

ADMS

Adamas Pharmaceuticals

$18.20

0.85 (4.90%)

, AGIO

Agios Pharmaceuticals

$65.89

2.51 (3.96%)

05:18
10/15/18
10/15
05:18
10/15/18
05:18
Recommendations
Adamas Pharmaceuticals, Agios Pharmaceuticals, Alnylam, Alexion, Bluebird Bio, BioMarin, CymaBay, Crispr Therapeutics, Global Blood Therapeutics, Horizon Pharma, Jazz Pharmaceuticals, Ocular Therapeutix, Rigel Pharmaceuticals, Xencor analyst commentary at Piper Jaffray »

Piper lists names to own…

ADMS

Adamas Pharmaceuticals

$18.20

0.85 (4.90%)

AGIO

Agios Pharmaceuticals

$65.89

2.51 (3.96%)

ALNY

Alnylam

$82.00

2.51 (3.16%)

ALXN

Alexion

$121.91

2.62 (2.20%)

BLUE

Bluebird Bio

$125.92

-0.81 (-0.64%)

BMRN

BioMarin

$99.60

2.28 (2.34%)

CBAY

CymaBay

$10.19

0.19 (1.90%)

CRSP

Crispr Therapeutics

$37.74

0.85 (2.30%)

GBT

Global Blood Therapeutics

$33.01

1.46 (4.63%)

HZNP

Horizon Pharma

$18.27

0.23 (1.27%)

JAZZ

Jazz Pharmaceuticals

$158.82

3.42 (2.20%)

OCUL

Ocular Therapeutix

$6.09

-0.02 (-0.33%)

RIGL

Rigel Pharmaceuticals

$3.10

0.005 (0.16%)

XNCR

Xencor

$35.08

1.04 (3.06%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 17

    Oct

  • 19

    Oct

  • 19

    Oct

  • 23

    Oct

  • 24

    Oct

  • 25

    Oct

  • 27

    Oct

  • 07

    Nov

  • 27

    Nov

  • 01

    Dec

  • 20

    Dec

  • 28

    Dec

  • 18

    Feb

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.